Cognitive Function After Radiation Therapy for Primary Brain Tumours
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity of Aarhus
About this trial
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.
Eligibility criteria
Qualifiers
18 years or older and Danish speaking.
Performance status WHO 0-2
Capable of cooperating on testing
Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas
Disqualifiers
Glioblastoma
Performance status 3-4 (Karnofsky Performances of 60 or less)
Trial design
Treatments tested in this trial
- Cognitive tests and Patient Reported Outcomes
Treatment groups
No treatment groups listed
Locations
5Department of Oncology, Rigshospitalet2100, CopenhagenCapital Region, Denmark
Danish Center for Particel Therapy8200, AarhusRegion Midt, Denmark
Department of Oncology, Aarhus University Hospital8200, AarhusRegion Midt, Denmark
Department of Oncology, Aalborg University Hospital9000, AalborgRegion Nord, Denmark
Sponsors and collaborators
University of Aarhus
Lead sponsor
Source ClinicalTrials.gov